BMAL1-mediated transcriptional regulation of CYP3A13 drives circadian rhythms in intestinal first-pass metabolism

Apr 18, 2026Biochemical pharmacology

How BMAL1 controls CYP3A13 to create daily rhythms in gut drug processing

AI simplified

Abstract

CYP3A13 expression is significantly higher during the night compared to the day.

  • The CYP3A family is primarily expressed in the jejunum, with CYP3A13 being the most prevalent isoform.
  • CYP3A13 exhibits a robust circadian rhythm in expression and metabolic activity.
  • The circadian clock gene Bmal1 is associated with the regulation of CYP3A13 expression and function.
  • Bmal1 directly activates CYP3A13 by binding to an E-box element, as shown through luciferase reporter assays and chromatin immunoprecipitation (ChIP).
  • The findings suggest that circadian rhythms may influence the metabolism of orally administered drugs like verapamil.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free